“La ivermectina es efectiva contra ómicron en ensayo de fase III”.”
Social media posts
Publicaciones en redes sociales. Claim dated 31 Jan 2022.
FactCheck.org rated thisFalso
What FactCheck.org found
Una empresa japonesa encontró que en pruebas de laboratiorio, el medicamento antiparasitario ivermectina mostraba un “efecto antiviral” contra la variante ómicron -- no en ensayos clínicos de Fase III.
Their words, from the summary they publish with the rating.
In short
This claim spread on social media around 31 January 2022. FactCheck.org (United States) looked into it and published its finding on 11 February 2022, 11 days later. Its rating was “Falso”.
Where the claim appeared
Links recorded by FactCheck.org. Some posts may have been deleted since.
This check was done by FactCheck.org, not by DoesItStand. We list it so you can find it. Their full evidence and reasoning are in their article.